[250 Pages Report] The global hybrid grafts market is expected to reach a valuation of US$ 517.3 Mn by the end of 2022, and further expand at a CAGR of 5.20% in 2022-2032. As per the report, the market is likely to reach a valuation of ~US$ 858.7 Mn by the end of 2032.
| Attribute | Key Statistics |
|---|---|
| Global Hybrid Grafts Market Estimated Size (2022E) | US$ 517.3 Mn |
| Projected Market Valuation (2032F) | US$ 858.7 Mn |
| Value-based CAGR (2022-2032) | 5.20% |
| Collective Value Share: Top 5 Countries (2022E) | 51.50% |
Hybrid grafts are extensively manufactured for their unique capabilities in the field of surgery worldwide. These products are designed in such a way that they can easily challenge traditional surgical procedures.
Hybrid grafts are set to be used for those patients having a small hamstring auto graft diameter. They enable surgeons to accelerate the overall size of grafts and develop a graft diameter of around 8mm or more.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global hybrid grafts market exhibited a CAGR of approximately 16.6% and reached a valuation of ~US$ 2.96 Bn in the global vascular grafts market in 2021.
Demand for hybrid grafts will continue to grow with increasing number of cardiac and vascular surgeries across the globe. With the emergence of technologically advanced methods and instruments, need for minimally invasive procedures is likely to surge at a rapid pace.
Minimally invasive procedures can reduce the physical and economic burden placed on patients by enabling a shorter stay in intensive care units or hospitals. The recovery rate is also faster than that of traditional surgical procedures. Patients who are unable to undergo open surgeries due to complications can easily opt for hybrid graft as it is minimally invasive and less painful.
Prevalence of aortic aneurysms (AAs) has increased in the last two decades owing to growing aging population, increasing number of smokers, implementation of screening programs, and availability of improved diagnostic methods. According to the CDC, in 2019, about 9,904 deaths in the U.S. occurred due to aortic aneurysms or aortic dissections.
Moreover, peripheral arterial disease (PAD) affects nearly 12%–14% of the general population. Its incidence rises with age, with up to 20% of individuals above the age of 75 suffering from the disease. Some of the major risk factors for PAD include smoking, hyperlipidemia, hypertension, diabetes, and metabolic syndrome.
Males and the elderly are more likely to develop PAD. High level of cholesterol is another crucial factor that may lead to PAD among the geriatric population.
Thus, increasing prevalence of PAD and AAs across the globe is projected to help the global hybrid grafts market to grow at a CAGR of 5.20% during the forecast period from 2022 to 2032.
The global hybrid grafts market is set to create new growth opportunities owing to ongoing development of novel thoracic aortic grafts. Increasing burden of chronic diseases is also expected to drive the market in the upcoming decade.
Rising number of health issues such as high cholesterol and blood pressure among the aging population is set to result in aortic aneurysms. Development of aortic aneurysms is projected to make them more vulnerable to contracting diseases, thereby pushing demand for hybrid grafts.
Cases of sudden injuries are also very common among the aging population. Surging prevalence of cancer and cardiovascular diseases is another vital factor that would contribute to the growth.
As per the WHO, about 17.9 million people die every year because of cardiovascular diseases worldwide and nearly 85% of all deaths associated with cardiovascular diseases are due to strokes and heart attacks. Increasing adoption of minimally invasive procedures on the back of enhanced recovery rates and low hospital stays is thus estimated to propel the global hybrid grafts market.
Principal Consultant
Graft rejection is considered to be one of the major drawbacks in the global hybrid grafts market. Prevalence of graft rejection is projected to grow at a fast pace as medication management is unable to prevent the same.
High cost of endovascular aneurysm repair treatments is another concern in the global market. Cost of treatment is likely to be unaffordable for a huge percentage of the middle- and lower-middle-class community. Spurred by the aforementioned limitations, demand for hybrid grafts may decline in the forthcoming years.
“Key Players Are Developing Thoracic Aortic Grafts in the U.S.”
The U.S. held approximately 38.2% of the global hybrid grafts market share in 2021. Presence of favourable reimbursement policies and increasing incidence of aortic aneurysm are projected to drive the market in the country.
Further, higher adoption of smoking habits and surging dependence on minimally invasive procedures are contributing to the growth in the United States. Companies in the U.S. are also focusing on the development of thoracic aortic grafts to meet the ever-increasing demand from patients, which would aid growth.
“Rising Prevalence of Cardiac and Vascular Diseases to Drive Germany”
Germany held a share of about 3.5% in 2021 and is projected to dominate the global hybrid grafts market in the assessment period. Expansion of the healthcare sector, increasing male geriatric population, advancements in minimally invasive procedures, and rising patient pool suffering from cardiac and vascular diseases are anticipated to drive growth.
As per a 2018 study conducted by the German Federal Statistical Office, incidence of thoracic aortic aneurysm repair has grown in Germany. Aneurysms were found in around 48,098 individuals and the age accounted was above 69, with 65.2 percent of the population being male.
Hypertension (74.9%), coronary heart disease (26.2%),peripheral artery disease (particularly abdominal aortic aneurysm, 42.6%), and other heart illnesses (41.6%) were the most common comorbidities that were found in the country.
Increasing number of endovascular repairing procedures that are conducted to combat the prevalence of aneurysm is another significant factor that would create high demand for hybrid grafts in Germany.
“Hybrid Grafts to Be Used for Endovascular Aneurysm Repair Procedures”
China hybrid grafts market is estimated to generate nearly 3.8% of share during the forecast period (2022-2032). Ongoing development of the country’s healthcare industry with the addition of innovative products and high patient holding capacity is expected to bode well for the market.
Easy availability of premium quality, yet cost-effective medical instruments in China is also likely to push the market. Increasing number of endovascular aneurysm repair (EVAR) procedures in the country is another vital factor that would aid sales of hybrid grafts.
Moreover, leading Chinese medical device companies are aiming to enter untapped areas for increasing their sales, which would further accelerate growth in the hybrid grafts market in China during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Thoracic Aortic Grafts to Gain Impetus with Prevalence of Chronic Diseases”
Based on product, the thoracic aortic grafts segment is expected to exhibit high growth at a CAGR of 5.6% in the forecast period and hold a share of about 78.2% in the global hybrid grafts market in 2032. Thoracic aortic grafts are gaining traction due to rising prevalence of various chronic diseases with the adoption of unhealthy lifestyles.
Recent developments and modifications in the field of thoracic aortic grafts on the back of changing raw materials and processing techniques are further expected to boost growth of the segment in the global hybrid grafts market.
“Hospitals to Conduct More Surgical Procedures in Future”
Based on end user, hospitals held the highest hybrid grafts market share of 59.2% in 2021. Growing prevalence of cardiac and vascular diseases, as well as increasing number of surgical procedures would drive the segment, thereby propelling sales of hybrid grafts in the evaluation period.
The global hybrid grafts market is moderately fragmented with the presence of various key players. To meet the high consumer demand and expand their customer base, these companies are developing new materials and manufacturing techniques.
Some of the recent industry developments by key players in the hybrid grafts market are given below:
| Attribute | Details |
|---|---|
| Estimated Market Size (2022) | US$ 517.3 Mn |
| Projected Market Valuation (2032) | US$ 858.7 Mn |
| Value-based CAGR (2022-2032) | 5.20% |
| Forecast Period | 2022-2032 |
| Historical Data Available for | 2017-2021 |
| Market Analysis | US$ Mn for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, Egypt, GCC, and South Africa |
| Key Market Segments Covered | Product, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives |
The global hybrid grafts market was worth US$ 491.7 Mn in 2021 and is set to expand 1.7x over the next ten years.
The hybrid grafts market is expected to reach US$ 858.7 Mn by the end of 2032 and register 5.20% CAGR.
Growing awareness about minimally invasive procedures, rising geriatric population, risks associated with open surgery, and high prevalence of cardiac & vascular diseases are some of the key trends in the market.
The U.S., China, Germany, the U.K., and India are expected to drive demand for hybrid grafts.
The U.S. accounted for about 38.2% of the North America hybrid grafts market share in 2021.
Europe hybrid grafts market is projected to exhibit growth at a CAGR of 8.1% over the next ten years.
The U.S., Germany, and China are the key producers of hybrid grafts.
Terumo Corporation, BD Interventional, Getinge AB, Merit Medical Systems, Inc., and JOTEC GmbH are some of the key players in the hybrid grafts market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption/ Usage Analysis
4.2. Product Innovation and Market Sustainability Analysis
4.3. Value Chain Analysis
4.4. Key Promotional Strategies, By Manufacturers
4.5. PESTLE Analysis
4.6. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Market Growth Outlook
5.1.2. Global Vascular Grafts Market Overview
5.1.3. Global GDP and Infrastructure Investment
5.2. Forecast Factors - Relevance & Impact
5.2.1. High Geriatric Population
5.2.2. Prevalence of Smoking
5.2.3. Increasing Number of Screening Methods
5.2.4. Adoption of Minimally-Invasive Procedures
5.2.5. Awareness related to the Risk of Open Surgery
5.2.6. Rules and Regulatory Scenarios
5.2.7. Government Funding
5.2.8. Strengthening Research and Development
5.3. Value Chain
5.3.1. Raw Material Suppliers
5.3.2. Product Manufacturers
5.3.3. End Users
5.4. COVID-19 Crisis – Impact Assessment
5.4.1. Current Statistics
5.4.2. Short-Mid-Long Term Outlook
5.4.3. Likely Rebound
5.5. Market Dynamics
5.5.1. Drivers
5.5.2. Restraints
5.5.3. Opportunity Analysis
5.6. Global Supply Demand Analysis
6. Global Hybrid Grafts Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032
6.1. Historical Market Volume (Units) Analysis, 2017–2021
6.2. Current and Future Market Size (US$ Mn) and Forecast Projections, 2022–2032
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Hybrid Grafts Market - Pricing Analysis
7.1. Regional Pricing Analysis By Product
7.2. Global Average Pricing Analysis Benchmark
8. Global Hybrid Grafts Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032
8.1. Historical Market Value (US$ Mn) Analysis, 2017–2021
8.2. Current and Future Market Size (US$ Mn) and Forecast Projections, 2022–2032
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Mn) and Volume(Units) Analysis and By Product, 2017–2021
9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032
9.3.1. Thoracic Aortic Graft
9.3.2. Peripheral Vascular Graft
9.4. Market Attractiveness Analysis By Product
10. Global Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021
10.3. Current and Future Market Size (US$ Mn) and Forecast By End User, 2022–2032
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.4. Market Attractiveness Analysis By End User
11. Global Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021
11.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East & Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021
12.4. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product, 2022–2032
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.2. By Product
12.4.3. By End User
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product
12.5.3. By End User
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
12.9. Country Level Analysis & Forecast
12.9.1. U.S. Hybrid Grafts Market
12.9.1.1. Introduction
12.9.1.2. Market Analysis and Forecast by Market Taxonomy
12.9.1.2.1. By Product
12.9.1.2.2. By End User
12.9.2. Canada Hybrid Grafts Market
12.9.2.1. Introduction
12.9.2.2. Market Analysis and Forecast by Market Taxonomy
12.9.2.2.1. By Product
12.9.2.2.2. By End User
13. Latin America Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021
13.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Argentina
13.4.1.4. Rest of Latin America
13.4.2. By Product
13.4.3. By End User
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product
13.5.3. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
13.9. Country Level Analysis & Forecast
13.9.1. Brazil Hybrid Grafts Market
13.9.1.1. Introduction
13.9.1.2. Market Analysis and Forecast by Market Taxonomy
13.9.1.2.1. By Product
13.9.1.2.2. By End User
13.9.2. Mexico Hybrid Grafts Market
13.9.2.1. Introduction
13.9.2.2. Market Analysis and Forecast by Market Taxonomy
13.9.2.2.1. By Product
13.9.2.2.2. By End User
13.9.3. Argentina Hybrid Grafts Market
13.9.3.1. Introduction
13.9.3.2. Market Analysis and Forecast by Market Taxonomy
13.9.3.2.1. By Product
13.9.3.2.2. By End User
14. Europe Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021
14.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. Italy
14.4.1.3. France
14.4.1.4. U.K.
14.4.1.5. Spain
14.4.1.6. BENELUX
14.4.1.7. Nordic Countries
14.4.1.8. Russia
14.4.1.9. Rest of Europe
14.4.2. By Product
14.4.3. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Product
14.5.2. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
14.9. Country Level Analysis & Forecast
14.9.1. Germany Hybrid Grafts Market
14.9.1.1. Introduction
14.9.1.2. Market Analysis and Forecast by Market Taxonomy
14.9.1.2.1. By Product
14.9.1.2.2. By End User
14.9.2. France Hybrid Grafts Market
14.9.2.1. Introduction
14.9.2.2. Market Analysis and Forecast by Market Taxonomy
14.9.2.2.1. By Product
14.9.2.2.2. By End User
14.9.3. Italy Hybrid Grafts Market
14.9.3.1. Introduction
14.9.3.2. Market Analysis and Forecast by Market Taxonomy
14.9.3.2.1. By Product
14.9.3.2.2. By End User
14.9.4. Spain Hybrid Grafts Market
14.9.4.1. Introduction
14.9.4.2. Market Analysis and Forecast by Market Taxonomy
14.9.4.2.1. By Product
14.9.4.2.2. By End User
14.9.5. U.K. Hybrid Grafts Market
14.9.5.1. Introduction
14.9.5.2. Market Analysis and Forecast by Market Taxonomy
14.9.5.2.1. By Product
14.9.5.2.2. By End User
14.9.6. Benelux Union Hybrid Grafts Market
14.9.6.1. Introduction
14.9.6.2. Market Analysis and Forecast by Market Taxonomy
14.9.6.2.1. By Product
14.9.6.2.2. By End User
14.9.7. Nordic Countries Hybrid Grafts Market
14.9.7.1. Introduction
14.9.7.2. Market Analysis and Forecast by Market Taxonomy
14.9.7.2.1. By Product
14.9.7.2.2. By End User
14.9.8. Russia Hybrid Grafts Market
14.9.8.1. Introduction
14.9.8.2. Market Analysis and Forecast by Market Taxonomy
14.9.8.2.1. By Product
14.9.8.2.2. By End User
15. South Asia Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021
15.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032
15.4.1. By Country
15.4.1.1. India
15.4.1.2. Thailand
15.4.1.3. Indonesia
15.4.1.4. Malaysia
15.4.1.5. Rest of South Asia
15.4.2. By Product
15.4.3. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
15.9. Country Level Analysis & Forecast
15.9.1. India Hybrid Grafts Market
15.9.1.1. Introduction
15.9.1.2. Market Analysis and Forecast by Market Taxonomy
15.9.1.2.1. By Product
15.9.1.2.2. By End User
15.9.2. Indonesia Hybrid Grafts Market
15.9.2.1. Introduction
15.9.2.2. Market Analysis and Forecast by Market Taxonomy
15.9.2.2.1. By Product
15.9.2.2.2. By End User
15.9.3. Malaysia Hybrid Grafts Market
15.9.3.1. Introduction
15.9.3.2. Market Analysis and Forecast by Market Taxonomy
15.9.3.2.1. By Product
15.9.3.2.2. By End User
15.9.4. Thailand Hybrid Grafts Market
15.9.4.1. Introduction
15.9.4.2. Market Analysis and Forecast by Market Taxonomy
15.9.4.2.1. By Product
15.9.4.2.2. By End User
16. East Asia Hybrid Grafts Market Analysis 2017–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021
16.4. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.2. By Product
16.4.3. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
16.9. Country Level Analysis & Forecast
16.9.1. China Hybrid Grafts Market
16.9.1.1. Introduction
16.9.1.2. Market Analysis and Forecast by Market Taxonomy
16.9.1.2.1. By Product
16.9.1.2.2. By End User
16.9.2. Japan Hybrid Grafts Market
16.9.2.1. Introduction
16.9.2.2. Market Analysis and Forecast by Market Taxonomy
16.9.2.2.1. By Product
16.9.2.2.2. By End User
16.9.3. South Korea Hybrid Grafts Market
16.9.3.1. Introduction
16.9.3.2. Market Analysis and Forecast by Market Taxonomy
16.9.3.2.1. By Product
16.9.3.2.2. By End User
17. Oceania Hybrid Grafts Market Analysis 2017-2021 and Forecast 2022–2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021
17.3. Current and Future Market Size (US$ Mn) and Volume(Units) Analysis and Forecast By Product, 2022–2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. Australia Hybrid Grafts Market
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By End User
17.8.2. New Zealand Hybrid Grafts Market
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By End User
18. Middle East and Africa (MEA) Hybrid Grafts Market Analysis 2017-2021 and Forecast 2022–2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis and By Product, 2017–2021
18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. Egypt
18.3.1.4. Israel
18.3.1.5. South Africa
18.3.1.6. North Africa
18.3.1.7. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Product
18.4.2. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. GCC Countries Hybrid Grafts Market
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By End User
18.8.2. Egypt Hybrid Grafts Market
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By End User
18.8.3. Turkey Hybrid Grafts Market
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By End User
18.8.4. South Africa Hybrid Grafts Market
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By End User
18.8.5. North Africa Hybrid Grafts Market
18.8.5.1. Introduction
18.8.5.2. Market Analysis and Forecast by Market Taxonomy
18.8.5.2.1. By Product
18.8.5.2.2. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
19.3.1. By Regional Footprint of Players
19.3.2. Product Footprint of Players
19.3.3. Channel Footprint of Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Terumo Corporation
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Key Financials
20.3.1.4. SWOT Analysis
20.3.1.5. Sales Footprint
20.3.1.6. Strategy Overview
20.3.1.6.1. Marketing Strategy
20.3.1.6.2. Product Strategy
20.3.1.6.3. Channel Strategy
20.3.2. BD Interventional
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Key Financials
20.3.2.4. SWOT Analysis
20.3.2.5. Sales Footprint
20.3.2.6. Strategy Overview
20.3.2.6.1. Marketing Strategy
20.3.2.6.2. Product Strategy
20.3.2.6.3. Channel Strategy
20.3.3. Getinge AB
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Key Financials
20.3.3.4. SWOT Analysis
20.3.3.5. Sales Footprint
20.3.3.6. Strategy Overview
20.3.3.6.1. Marketing Strategy
20.3.3.6.2. Product Strategy
20.3.3.6.3. Channel Strategy
20.3.4. Merit Medical Systems, Inc.
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Key Financials
20.3.4.4. SWOT Analysis
20.3.4.5. Sales Footprint
20.3.4.6. Strategy Overview
20.3.4.6.1. Marketing Strategy
20.3.4.6.2. Product Strategy
20.3.4.6.3. Channel Strategy
20.3.5. JOTEC GmbH
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Key Financials
20.3.5.4. SWOT Analysis
20.3.5.5. Sales Footprint
20.3.5.6. Strategy Overview
20.3.5.6.1. Marketing Strategy
20.3.5.6.2. Product Strategy
20.3.5.6.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Hybrid Grafts Market
